Sage therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Sage therapeutics Contact Number

Contact Us Sage Therapeutics

4 hours ago Sagerx.com Show details

Discover Sage in Raleigh. Sage Therapeutics 7751 Brier Creek Parkway Raleigh, NC 27617

Category: Contact SupportShow more

Sage Therapeutics, Inc. Company Profile Cambridge, MA

5 hours ago Dnb.com Show details

(617) 299-8380Find company research, competitor information, contact details & financial data for Sage Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.

Employees: 298
Phone: (617) 299-8380
Location: 215 1ST St, Cambridge, 02142-1213, MA

Category: Contact NumberShow more

SAGE Therapeutics Crunchbase Company Profile & …

7 hours ago Crunchbase.com Show details

Legal Name SAGE Therapeutics Inc. Stock Symbol NASDAQ:SAGE. Company Type For Profit. Contact Email [email protected] Phone Number 6172998379. SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's

Founder: Douglas Covey, Steven Paul
Location: Cambridge, Massachusetts
Founded: Jan 01, 2010

Category: Contact NumberShow more

Sage Therapeutics Biopharmaceutical Company for

3 hours ago Sagerx.com Show details

Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.

Category: Contact NumberShow more

SAGE THERAPEUTICS LIMITED Company Profile …

9 hours ago Dnb.com Show details

SAGE THERAPEUTICS LIMITED is located in LONDON, United Kingdom and is part of the Pharmaceutical and Medicine Manufacturing Industry. SAGE THERAPEUTICS LIMITED has 4 employees at this location and generates $1.04 million in sales (USD). (Employees figure is estimated, Sales figure is modelled).

Employees: 4
Location: 100 New Bridge Street, LONDON, EC4V 6JA

Category: Contact NumberShow more

Sage Therapeutics Information Sage Therapeutics Profile

5 hours ago Rocketreach.co Show details

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and our depression, neurology and neuropsychiatry franchise programs aim to change how brain

Category: Contact NumberShow more

Biogen Idec Inc. (NASDAQ:BIIB), (SAGE) Sage Therapeutics

9 hours ago Benzinga.com Show details

1 day ago · Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc (NASDAQ: BIIB) have announced 12-month data for the cohort of patients (n=199) who received zuranolone 50 mg once for 14-days as their initial

Category: Contact NumberShow more

Cole Brown Medical Affairs He.. Sage Therapeutics

8 hours ago Zoominfo.com Show details

View Cole Brown's business profile as Medical Affairs Head (US) at Sage Therapeutics. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Martha ChadwickWalker Servic.. Sage Therapeutics

Just Now Zoominfo.com Show details

(617) 299-8380View Martha Chadwick-Walker's business profile as Services Associate Director, Information Technology at Sage Therapeutics. Find contact's direct phone number, email address, work history, and more.

Works For: Sage Therapeutics
Phone: (617) 299-8380
Location: 215 First Street, Cambridge, 02142, Massachusetts

Category: Contact NumberShow more

Sage Therapeutics Email Format sagerx.com Emails

Just Now Rocketreach.co Show details

Sage Therapeutics Email Format. Sage Therapeutics uses 1 email formats, with first '.' last (ex. [email protected]) being used 100.0% of the time. Get Verified Emails for Sage Therapeutics Employees. Sage Therapeutics's Email Format. Percentage.

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Plans to Submit a

2 hours ago Investor.sagerx.com Show details

(617) 949-4289SAGE MEDIA CONTACT: Maureen L. Suda (617) 949-4289 [email protected] SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected] BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected] BIOGEN INVESTOR CONTACT: Mike Hencke +1 781 464 …

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Consistent

2 hours ago Investor.sagerx.com Show details

(617) 949-4289SAGE MEDIA CONTACT: Maureen L. Suda (617) 949-4289 [email protected] BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected] SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected] BIOGEN INVESTOR CONTACT: Mike Hencke +1 781 464 …

Category: Contact NumberShow more

Sage Therapeutics Company Profile Office Locations

4 hours ago Craft.co Show details

Sage Therapeutics has 675 employees across 2 locations and $1.11 B in annual revenue in FY 2020. See insights on Sage Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Sage office in Raleigh Sage Therapeutics Careers

4 hours ago Careers.sagerx.com Show details

Sage office in Raleigh Sage Therapeutics Careers. -. Our Sage office in Raleigh, North Carolina is home to our Patient Support team. Here is where so much of the direct work we do with CNS patients is carried out - and we feel privileged to be able to get the job done in such an inspiring environment. We’ve set up base in Research Triangle

Category: Contact NumberShow more

Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call

9 hours ago Fool.com Show details

Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript SAGE earnings call for the period ending September 30, 2021.

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Positive, OneYear

1 hours ago Financialbuzz.com Show details

908-205-25721 day ago · BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected] SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected] BIOGEN INVESTOR CONTACT

Category: Contact NumberShow more

SAGE Therapeutics Employees, Board Members, Advisors

4 hours ago Crunchbase.com Show details

SAGE Therapeutics has 17 board members and advisors, including Robert Nelsen. Robert Nelsen Board Member. Molly Huntsman Advisor. Kevin Starr Board Member Jan 2011. Michael Rogawski Advisor. Stephen Moss Advisor. William Muir Advisor. Mark Dershwitz Advisor. Scott Grossman Advisor.

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Consistent

2 hours ago Businesswire.com Show details

(617) 949-4289SAGE MEDIA CONTACT: Maureen L. Suda (617) 949-4289 [email protected] BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected]

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Positive, OneYear

8 hours ago Finance.yahoo.com Show details

CAMBRIDGE, Mass., December 01, 2021--Sage Therapeutics, Inc. (Nasdaq: SAGE), and Biogen Inc. (Nasdaq: BIIB) today announced 12-month data for the cohort of patients (n=199), who received

Category: Contact NumberShow more

Sage Therapeutics axes 2 zuranolone trials deemed

1 hours ago Fiercebiotech.com Show details

Sage Therapeutics terminated two long-suspended phase 3 zuranolone clinical trials after talks with the FDA led it to believe it can seek approval in major depressive disorder without data from

Category: Contact NumberShow more

Albert Robichaud Chief Scientific Officer Sage

Just Now Apollo.io Show details

SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, …

Category: Contact NumberShow more

Sage Therapeutics Announces Third Quarter 2021 Financial

7 hours ago Businesswire.com Show details

Sage expects to complete certain ongoing Phase 1 clinical studies for two programs in its early development pipeline in late 2021, SAGE-689 (single ascending dose) and SAGE-904 (single ascending

Category: Contact NumberShow more

Sage Therapeutics (NASDAQ:SAGE) Given "Buy" Rating at

Just Now Marketbeat.com Show details

Sage Therapeutics (NASDAQ:SAGE) 's stock had its "buy" rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Thursday, TipRanks reports. They currently have a $78.00 target price on the biopharmaceutical company's stock. Needham & Company LLC's price objective would indicate a potential upside of 93.45% …

Category: Contact NumberShow more

Is SAGE Therapeutics Inc (SAGE) Stock at the Top of the

Just Now Investorsobserver.com Show details

SAGE Therapeutics Inc is near the middle in its industry group according to InvestorsObserver.SAGE gets an overall rating of 42. That means it scores higher than 42 percent of stocks. SAGE Therapeutics Inc gets a 60 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.

Category: Contact NumberShow more

Emerging Drugs for the Treatment of Postpartum Depression

2 hours ago Finance.yahoo.com Show details

Sage Therapeutics is conducting a Phase III randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of SAGE-217 in treating adults with severe postpartum depression

Category: Contact NumberShow more

Guggenheim Upgrades Sage Therapeutics (SAGE) to Buy

8 hours ago Streetinsider.com Show details

Guggenheim analyst Yatin Suneja upgraded Sage Therapeutics (NASDAQ: SAGE) from Neutral to Buy with a price target of $55.00. For an analyst ratings summary and ratings history on Sage Therapeutics

Category: Contact NumberShow more

SAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q3 2021

8 hours ago Seekingalpha.com Show details

SAGE Therapeutics, Inc. (NASDAQ:SAGE) Q3 2021 Results Earnings Conference Call November 2, 2021, 08:00 AM ET Company Participants Helen Rubenstein - Investor Contact Barry Greene - Chief

Category: Contact NumberShow more

Sage Neuroscience Center

3 hours ago Sageclinic.org Show details

(505) 884-1114Sage Neuroscience Center is a multidisciplinary team of dedicated healthcare professionals restoring balance to mind and body. Contact Information All Services: 1 (505) 884-1114 Primary Care: 1 (505) 359-3033 Fax: 505-884-3004. 7850 Jefferson St. NE, Suite 300 Albuquerque, NM 87109

Category: Contact NumberShow more

Truist Securiti Comments on Sage Therapeutics, Inc.'s Q4

9 hours ago Marketbeat.com Show details

Sage Therapeutics (NASDAQ:SAGE) last issued its earnings results on Tuesday, November 2nd. The biopharmaceutical company reported ($2.21) EPS for the quarter, missing the Zacks' consensus estimate of ($1.84) by ($0.37). Sage Therapeutics had a negative return on equity of 23.27% and a net margin of 57.61%. During the same quarter in the prior

Category: Contact NumberShow more

Sage Therapeutics Number of Employees 20132021 SAGE

4 hours ago Macrotrends.net Show details

Sage Therapeutics number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Sage Therapeutics Announces Third Quarter 2021 Financial

2 hours ago Bloomberg.com Show details

021-11-02Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress. November 2, 2021, 6:30 AM EDT SHARE THIS ARTICLE. Share. Tweet.

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Positive, OneYear

3 hours ago Biospace.com Show details

(617) 949-42892 days ago · SAGE MEDIA CONTACT: Maureen L. Suda (617) 949-4289 [email protected] BIOGEN MEDIA CONTACT: Ashleigh Koss Tel: +1 908-205-2572 [email protected] SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected] BIOGEN INVESTOR CONTACT: Mike Hencke +1 781 464 …

Category: Contact NumberShow more

What 8 Analyst Ratings Have To Say About Sage Therapeutics

4 hours ago Benzinga.com Show details

According to 8 analyst offering 12-month price targets in the last 3 months, Sage Therapeutics has an average price target of $72.88 with a high of $84.00 and a low of $48.00. Below is a summary

Category: Contact NumberShow more

Thinking About Buying Sage Therapeutics Inc. Stock? Here’s

6 hours ago Stocksregister.com Show details

According to the data, the short interest in Sage Therapeutics Inc. (SAGE) stood at 7.10% of shares outstanding as of Jun 14, 2021; the number of short shares registered in May 13, 2021 reached 4.29 million. The stock has fallen by -47.82% since the beginning of the year, thereby showing the potential of a further growth.

Category: Contact NumberShow more

Sage Therapeutics Announces Third Quarter 2021 Financial

9 hours ago Marketscreener.com Show details

Today, Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the third quarter ended September 30, 2021.

Category: Contact NumberShow more

Sage Therapeutics : and Biogen Announce Plans to Submit a

4 hours ago Marketscreener.com Show details

CAMBRIDGE, Mass. - Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced their plan to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone, an investigational two-week, once-daily therapeutic in the second half of 2022. The planned initial submission package will seek …

Category: Contact NumberShow more

Grant Rutledge's email & phone number Senior Clinical

8 hours ago Signalhire.com Show details

View Grant Rutledge's email address: [email protected] & phone: +1-xxx-xxx-1070's profile as Senior Clinical Research Coordinator at Sage Therapeutics, located in Boston, Massachusetts. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Sage Therapeutics email format Sage Therapeutics.com emails

Just Now Aeroleads.com Show details

Sage Therapeutics uses 4 email formats, with (firstname) (l) (ex. [email protected]) being used 59.09% of the time. (firstname). (l) Sage Therapeutics employs 68 employees. The Sage Therapeutics management team includes Jeffrey Jonas (Chief Executive Officer). Search from 68 Sage Therapeutics employees, AeroLeads validates emails and finds

Category: Contact NumberShow more

Postpartum Depression Diagnosis, Treatment, and Market

1 hours ago Digitaljournal.com Show details

Contact Us. Yash. [email protected] Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Yash Bhardwaj Email: Send Email Phone: +919650213330 Address:304 S. Jones

Category: Contact NumberShow more

Sage Therapeutics and Biogen Announce Plans to Submit a

5 hours ago Marketwatch.com Show details

022-2021-10SOURCE: Sage Therapeutics, Inc. SAGE MEDIA CONTACT: Maureen L. Suda (617) 949-4289 [email protected] SAGE INVESTOR CONTACT: Helen Rubinstein (315) 382-3979 [email protected] BIOGEN

Category: Contact NumberShow more

Healthcare Providers Enrollment Information Check on Mom

9 hours ago Mycheckonmom.com Show details

The mission of the Check on Mom program is to create a movement that helps moms proactively develop a maternal mental wellness plan and establish a “mom team”—a network of support that is educated and activated to help moms in their maternal mental health goals and to recognize the signs and symptoms of postpartum depression.

Category: Contact NumberShow more

Sage Therapeutics Announces Second Quarter 2021 Financial

1 hours ago Nz.finance.yahoo.com Show details

CAMBRIDGE, Mass., August 03, 2021--Today, Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the second quarter ended June 30, 2021.

Category: Contact NumberShow more

Nathalie Belfort Accounts Payable Specialist Sage

Just Now Apollo.io Show details

View Nathalie Belfort's business profile as Accounts Payable Specialist at Sage Therapeutics. Find Nathalie's email address, mobile number, work history, and more.

Category: Contact NumberShow more

VA National Acquisition Center Contract Catalog Search Tool

3 hours ago Vendorportal.ecms.va.gov Show details

The National Acquisition Center Contract Catalog Search Tool now allows your facility to browse MedSurg and Pharmaceutical products and services available under Federal Supply Service contracts. The search tool allows the user to locate items using a variety of search criteria, including item description, special item number (SIN) and contract number.

Category: Contact NumberShow more

Benefits Careers at Sage Therapeutics

5 hours ago Careers.sagerx.com Show details

At Sage, we believe great work deserves great recognition and rewards. We take care of our employees, and we’re totally committed to their well-being and happiness. Start working with Sage and get the extensive incentive and benefits package.

Category: Contact NumberShow more

Sage (SAGE), Biogen (BIIB) Report Data on Depression Drug

4 hours ago Nasdaq.com Show details

13 hours ago · Sage Therapeutics, Inc. SAGE along with partner Biogen Inc. BIIB announced 12-month data from a cohort of an ongoing phase III SHORELINE study, currently evaluating their drug zuranolone in adult

Category: Contact NumberShow more

Sage Therapeutics And Biogen Announce OneYear Zuranolone

6 hours ago Webull.com Show details

Sage Therapeutics, Inc. (NASDAQ:SAGE), and Biogen Inc. (NASDAQ:BIIB) today announced 12-month data for the cohort of patients (n=199), who received zuranolone 50 mg once nightly for 14-days as their initial dose in the ongoing Phase 3 open-label SHORELINE Study and had the opportunity to be followed for 12-months. The SHORELINE Study, part of

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What's new at SAGE Therapeutics?

Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder At Sage, we believe we see possibilities where others do not and are working to find potential ways to treat people with brain health disorders.

What is sage doing for You?

Sage is committed to developing new medicines to treat life-altering brain health disorders. We seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential brain health disorder treatments.

Why choose Sage Neuroscience Center?

For over 14 years now Sage Neuroscience Center has been helping adolescents and adult patients with addiction, detox and behavioral health issues such as anxiety, depression and PTSD. Learn More About Us Our Treatment Services and Programs

Why did SAGE Therapeutics cancel two phase 3 Zuranolone clinical trials?

Sage Therapeutics terminated two long-suspended phase 3 zuranolone clinical trials after talks with the FDA led it to believe it can seek approval in major depressive disorder (MDD) without data from those studies. The biotech shared the update alongside news of a delay to data from another phase 3 because of slow enrollment during the pandemic.

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea